ストックスクリーナーアプリを入手
0.6596
0.08%
-0.0005
前日終値:
$0.6601
開ける：
$0.66
24時間の取引高:
73,264
Relative Volume:
0.38
時価総額：
$1.02M
収益：
$743.00K
当期純損益:
$-7.63M
株価収益率:
-0.2199
EPS:
-3
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+1.26%
1か月 パフォーマンス:
-0.06%
6か月 パフォーマンス:
-57.45%
1年 パフォーマンス:
-72.97%
1日の値動き範囲:
$0.655
$0.6666
1週間の範囲:
$0.65
$0.6699
52週間の値動き範囲:
$0.6301
$3.12
Can-Fite Biopharma Ltd ADR Stock (CANF) Company Profile
名前
Can-Fite Biopharma Ltd ADR
セクター
電話
972 3 924 1114
住所
10 Bareket Street, Kiryat Matalon PO Box 7537, Petah-Tikva
CANF を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CANF
Can-Fite Biopharma Ltd ADR
|
0.6596 | 10.34M | 743.00K | -7.63M | 0 | -3.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Can-Fite Biopharma Ltd ADR Stock (CANF) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2017-08-11 | 開始されました | Maxim Group | Buy |
| 2016-10-19 | 再開されました | ROTH Capital | Buy |
| 2016-08-29 | 再開されました | Rodman & Renshaw | Buy |
| 2015-11-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-03-31 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-03-30 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2014-12-29 | 繰り返されました | ROTH Capital | Buy |
| 2014-11-18 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Can-Fite Biopharma Ltd ADR (CANF) 最新ニュース
Can-Fite BioPharma (NYSE:CANF) Given Buy Rating at D. Boral Capital - Defense World
Can swing trading help recover from Crane NXT Co. lossesMarket Growth Summary & AI Optimized Trade Strategies - Newser
Has FVRR formed a bullish divergence2025 Key Lessons & Low Risk High Win Rate Picks - Newser
Applying sector rotation models to Vale S.A. Depositary ReceiptJuly 2025 Catalysts & Reliable Price Action Trade Plans - Newser
Sentiment analysis tools applied to Vertical Aerospace Ltd.2025 Dividend Review & Weekly Setup with ROI Potential - Newser
Using RSI to spot recovery in ALDFUJuly 2025 Market Mood & Precise Swing Trade Entry Alerts - Newser
Fragrances Inc.Earnings Growth Report & Stepwise Swing Trade Plans - Newser
Full technical analysis of POST stockMarket Sentiment Summary & Breakout Confirmation Trade Signals - Newser
What indicators show strength in Enterprise Products Partners L.P. Limited PartnershipIn-Depth Stock Trading Volume Analysis - Newser
Can-Fite reaches 50% enrollment milestone in pancreatic cancer trial By Investing.com - Investing.com South Africa
Can-Fite reaches 50% enrollment milestone in pancreatic cancer trial - Investing.com
Can-Fite BioPharma prices $5 million public offering of ADSs - Investing.com
Can-Fite BioPharma prices $5 million public offering of ADSs By Investing.com - Investing.com India
Harbour Energy Begins First Oil Production From Maria Phase 2 - The Globe and Mail
Can Fite Biopharma stock hits 52-week low at $1.14 By Investing.com - Investing.com South Africa
Can Fite Biopharma stock hits 52-week low at $1.14 - Investing.com
Can Fite Biopharma stock hits 52-week low at $1.22 By Investing.com - Investing.com South Africa
Can Fite Biopharma stock hits 52-week low at $1.22 - Investing.com
Can-Fite BioPharma announces $3M registered direct offering - Investing.com
Can-Fite’s Surging Stock: Is It Time to Act? - timothysykes.com
Can Fite Biopharma stock hits 52-week low at $1.86 - Investing.com
Can-Fite's partner Vetbiolix secures $325M deal for dog arthritis drug - Investing.com
List of Israeli Stocks Traded on the NYSE Worth Considering - The Times of Israel
Can-Fite BioPharma seeks FDA nod for NASH drug trial - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight - PR Newswire
Pacira's (PCRX) Q3 Earnings Miss Estimates, Revenues Beat - Yahoo Finance
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
bioAffinity Technologies Inc Stock Price Today | NASDAQ: BIAF Live - Investing.com
Earnings Scheduled For November 30, 2020 - Yahoo Finance
4 Penny Stocks On Robinhood To Buy Under $4 Now; Worth The Risk? - Penny Stocks
10 Biopharmaceutical Companies Trying To Cure Cancer - Yahoo Finance
Can-Fite's Rheumatoid Arthritis Drug Faces Off With Methotrexate In Phase III Trial For $40 Billion Market (NYSE:CANF) - Seeking Alpha
Can-Fite Biopharma Ltd ADR (CANF) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):